Picture of Cabaletta Bio logo

CABA Cabaletta Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Cabaletta Bio Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update

March 16 (Reuters) - Cabaletta Bio Inc  CABA.O :
    * CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * AS OF DECEMBER 31, 2022, CABALETTA HAD CASH, CASH
EQUIVALENTS
AND INVESTMENTS OF $106.5 MILLION
    * EXPECTS TCASH, CASH EQUIVALENTS & INVESTMENTS AS OF DEC
31,
2022, WILL ENABLE IT TO FUND ITS OPERATING PLAN INTO Q1 OF 2025
    * EXPECTING IND CLEARANCE IN FIRST HALF OF 2023 FOR CABA-201
    * QTRLY NET LOSS PER SHARE $0.52
    * Q4 EARNINGS PER SHARE VIEW $-0.45 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbfqCZC 
Further company coverage:  CABA.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Cabaletta Bio

See all news